Synlett 2018; 29(18): 2377-2380
DOI: 10.1055/s-0037-1611024
letter
© Georg Thieme Verlag Stuttgart · New York

Total Synthesis of Lycoposerramine-R

Shinya Watanabe
,
Masatsugu Ishikawa
,
Toshimune Nomura
,
Tohru Fukuyama
,
Graduate School of Pharmaceutical Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan   Email: yokosima@ps.nagoya-u.ac.jp
› Author Affiliations
This work was financially supported by JSPS KAKENHI (Grant Numbers 16H01141 and 17H01523), by JSPS A3 Foresight Program, and by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research; BINDS) from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP18am0101099.
Further Information

Publication History

Received: 31 August 2018

Accepted: 25 September 2018

Publication Date:
16 October 2018 (online)


Zoom Image

Abstract

A total synthesis of lycoposerramine-R was accomplished. The synthesis featured a Claisen–Ireland rearrangement to install a two-carbon unit, and a hetero-Diels–Alder reaction to form a cyclic enol ether that reacted with an ethynyl group to construct a cis-hydrindane core containing a quaternary carbon. A 2-pyridone synthesis using 2-(phenylsulfinyl)acetamide was used to complete the synthesis.

Supporting Information

Crossref Cited-by logo
Article Citations